Bone Density, Biochemistry and Life-Style

Abstract:

We have assessed the relationship between bone density, biochemistry and life-style factors in a cross-sectional study of 434 pre- and 357 postmenopausal women. Bone-mineral content (BMC) was measured in the non-dominant forearm using single-photon densitometry. Bone mass was corrected for bone size (BMC2) in a sub-set of 263 subjects. Correlation statistics and multiple regression analyses were used to identify physical and biochemical measurements that could be used to best predict BMC or BMC2. These were combined with lifestyle factors, using multiple logistic regression analysis, to identify women at risk of low bone density. Cut-off values were taken as the 5th percentile of the bone density distributions in pre-menopausal women. In postmenopausal women, using BMC2 values to define “risk”, and using age, creatinine, alkaline phosphatase, thyroxine treatment, and calcium supplementation as predictors, a sensitivity of 73% and a specificity of 95% were achieved. Such a model may be of use as a “first pass” screening test for osteoporosis.

Key-Words

Bone Mineral Density - Osteoporosis - Predictive Models - Risk Factors - Screening

• REFERENCES

• 1 Fractured Neck of Femur . Prevention and Management. London: Royal College of Physicians; 1989
• 2 Cummings SR, Kelsey JL, Nevitt MC, O’Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 07: 178-208.
• 3 Melton III LJ, Riggs BL. Epidemiology of age-related fractures. In: Avioli LB. (ed). The Osteoporotic Syndrome. . New York: Grune and Stratton; 1983: 45-72.
• 4 Woolf AD. Osteoporosis, the silent epidemic. Osteoporosis Rev 1991; 01: 1-2.
• 5 Nordin BEC, Polley KJ. Metabolic consequences of the menopause: a cross-sectional, longitudinal, and intervention study on 557 normal postmenopausal women. Calcif Tissue Int. 1987 41. (Suppl 1).
• 6 Gambrell RD. Menopause: benefits and risks of estrogen-progestogen replacement therapy. Fertility and Sterility 1982; 37: 457-72.
• 7 Mack TM, Pike MC, Henderson BE. et al. Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976; 294: 1262-7.
• 8 Persson I, Adami H-O, Bergkvist L. et al. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. Br Med J 1989; 298: 147-51.
• 9 Hirvonen E, Mälkönen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 1981; 304: 560-3.
• 10 Tosteson ANA, Rosenthal DI, Melton III LJ, Weinstein MC. Cost effectiveness of screening for osteoporosis: bone densitometry and hormone replacement therapy. Ann Int Med 1990; 113: 594-603.
• 11 Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest 1981; 67: 328-35.